Trevi Therapeutics (TRVI) EPS (Basic) (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.01% |
| Dec 31, 2025 | 25.00% |
| Sep 30, 2025 | 11.11% |
| Jun 30, 2025 | -2.37% |
| Mar 31, 2025 | 20.08% |
| Dec 31, 2024 | 15.38% |
| Sep 30, 2024 | -8.33% |
| Jun 30, 2024 | -9.09% |
| Mar 31, 2024 | -37.50% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -14.29% |
| Jun 30, 2023 | -16.67% |
| Mar 31, 2023 | -500.00% |
| Dec 31, 2022 | 91.67% |
| Sep 30, 2022 | 14.29% |
| Jun 30, 2022 | 41.67% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 29.41% |
| Sep 30, 2021 | 30.61% |
| Jun 30, 2021 | -13.95% |
| Mar 31, 2021 | 15.69% |
| Dec 31, 2020 | -24.39% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 14.58% |
| Mar 31, 2020 | -152.63% |
| Dec 31, 2019 | 53.66% |
| Sep 30, 2019 | 34.92% |
| Jun 30, 2019 | 95.45% |
| Mar 31, 2019 | 17.36% |
| Dec 31, 2018 | -3.33% |
| Sep 30, 2018 | -19.09% |
| Jun 30, 2018 | -15.23% |